Renaissance Technologies’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$203K Buy
+19,500
New +$203K ﹤0.01% 3169
2025
Q1
Sell
-13,800
Closed -$247K 3776
2024
Q4
$247K Buy
+13,800
New +$247K ﹤0.01% 3101
2024
Q3
Sell
-17,052
Closed -$461K 3824
2024
Q2
$461K Sell
17,052
-1,401
-8% -$37.8K ﹤0.01% 2730
2024
Q1
$360K Buy
18,453
+1,193
+7% +$23.3K ﹤0.01% 3006
2023
Q4
$357K Sell
17,260
-6,940
-29% -$144K ﹤0.01% 2913
2023
Q3
$770K Sell
24,200
-9,217
-28% -$293K ﹤0.01% 2471
2023
Q2
$1.12M Sell
33,417
-2,353
-7% -$79.1K ﹤0.01% 2395
2023
Q1
$1.49M Sell
35,770
-5,059
-12% -$211K ﹤0.01% 2210
2022
Q4
$1.38M Buy
40,829
+10,659
+35% +$361K ﹤0.01% 2325
2022
Q3
$1.48M Buy
30,170
+10,557
+54% +$519K ﹤0.01% 2239
2022
Q2
$771K Sell
19,613
-30,067
-61% -$1.18M ﹤0.01% 2877
2022
Q1
$1.83M Buy
49,680
+33,807
+213% +$1.25M ﹤0.01% 2292
2021
Q4
$1.55M Buy
15,873
+7,133
+82% +$697K ﹤0.01% 2350
2021
Q3
$1.09M Sell
8,740
-5,535
-39% -$691K ﹤0.01% 2504
2021
Q2
$1.79M Buy
14,275
+4,792
+51% +$601K ﹤0.01% 2330
2021
Q1
$1.29M Sell
9,483
-22,891
-71% -$3.11M ﹤0.01% 2489
2020
Q4
$2.94M Buy
32,374
+15,829
+96% +$1.44M ﹤0.01% 1906
2020
Q3
$1.23M Sell
16,545
-21,360
-56% -$1.59M ﹤0.01% 2401
2020
Q2
$3.23M Sell
37,905
-11,258
-23% -$959K ﹤0.01% 1894
2020
Q1
$3.55M Buy
49,163
+20,021
+69% +$1.45M ﹤0.01% 1758
2019
Q4
$2.08M Buy
29,142
+7,996
+38% +$571K ﹤0.01% 2307
2019
Q3
$1.11M Buy
21,146
+5,429
+35% +$285K ﹤0.01% 2554
2019
Q2
$844K Buy
15,717
+7,794
+98% +$419K ﹤0.01% 2768
2019
Q1
$563K Buy
7,923
+4,200
+113% +$298K ﹤0.01% 2889
2018
Q4
$297K Buy
3,723
+3,303
+786% +$263K ﹤0.01% 3027
2018
Q3
$196K Buy
+420
New +$196K ﹤0.01% 3158